Fitness Trade-Offs inblaTEMEvolution

Antimicrobial Agents and Chemotherapy
2008.0

Abstract

bla(TEM-1) expression results in penicillin resistance, whereas expression of many bla(TEM-1) descendants, called extended-spectrum beta-lactamases (ESBLs), results simultaneously in resistance to penicillins and extended-spectrum cephalosporins. Despite the expanded resistance phenotypes conferred by many ESBLs, bla(TEM-1) is still the most abundant bla(TEM) allele in many microbial populations. This study examines the fitness effects of the two amino acid substitutions, R164S and E240K, that have occurred repeatedly among ESBL bla(TEM-1) descendants. Using a single-nucleotide polymorphism-specific real-time quantitative PCR method, we analyzed the fitness of strains expressing bla(TEM-1), bla(TEM-10), and bla(TEM-12). Our results show that bacteria expressing the ancestral bla(TEM-1) allele have a fitness advantage over those expressing either bla(TEM-10) or bla(TEM-12) when exposed to ampicillin. This observation, combined with the fact that penicillins are the most prevalent antimicrobials prescribed worldwide, may explain why bla(TEM-1) has persisted as the most frequently encountered bla(TEM) allele in bacterial populations.

Knowledge Graph

Similar Paper

Fitness Trade-Offs inbla<sub>TEM</sub>Evolution
Antimicrobial Agents and Chemotherapy 2008.0
TEM-168, a Heretofore Laboratory-Derived TEM β-Lactamase Variant Found in an Escherichia coli Clinical Isolate
Antimicrobial Agents and Chemotherapy 2009.0
Evolution of TEM-Type Enzymes: Biochemical and Genetic Characterization of Two New Complex Mutant TEM Enzymes, TEM-151 and TEM-152, from a Single Patient
Antimicrobial Agents and Chemotherapy 2007.0
Pyrosequencing Using the Single-Nucleotide Polymorphism Protocol for Rapid Determination of TEM- and SHV-Type Extended-Spectrum β-Lactamases in Clinical Isolates and Identification of the Novel β-Lactamase Genes bla <sub>SHV-48</sub> , bla <sub>SHV-105</sub> , and bla <sub>TEM-155</sub>
Antimicrobial Agents and Chemotherapy 2009.0
Ampicillin-Resistant Non-β-Lactamase-Producing Haemophilus influenzae in Spain: Recent Emergence of Clonal Isolates with Increased Resistance to Cefotaxime and Cefixime
Antimicrobial Agents and Chemotherapy 2007.0
TEM-158 (CMT-9), a New Member of the CMT-Type Extended-Spectrum β-Lactamases
Antimicrobial Agents and Chemotherapy 2007.0
Diversity of Ampicillin Resistance Genes and Antimicrobial Susceptibility Patterns in Haemophilus influenzae Strains Isolated in Korea
Antimicrobial Agents and Chemotherapy 2007.0
Contribution of BlaA and BlaB β-Lactamases to Antibiotic Susceptibility of Yersinia enterocolitica Biovar 1B
Antimicrobial Agents and Chemotherapy 2010.0
Selection of SHV Extended-Spectrum-β-Lactamase-Dependent Cefotaxime and Ceftazidime Resistance in Klebsiella pneumoniae Requires a Plasmid-Borne bla <sub>SHV</sub> Gene
Antimicrobial Agents and Chemotherapy 2008.0
Convergent In Vivo and In Vitro Selection of Ceftazidime Resistance Mutations at Position 167 of CTX-M-3 β-Lactamase in Hypermutable Escherichia coli Strains
Antimicrobial Agents and Chemotherapy 2008.0